SCHEMBL7006146

SCHEMBL7006146

N#CCCCCc1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.53
ADRA2A P08913 3/20 0.53
SLC6A2 P23975 3/20 0.53
ALDH1A1 P00352 3/20 0.53
ADORA3 P0DMS8 2/20 0.53
TACR2 P21452 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
KDM4E B2RXH2 2/20 0.53
CYP3A4 P08684 2/20 0.53
LMNA P02545 1/20 0.53
SHBG P04278 1/20 0.53
TP53 P04637 1/20 0.53
HSPD1 P10809 1/20 0.53
ADRB3 P13945 1/20 0.53
HTR2C P28335 1/20 0.53
HSPE1 P61604 1/20 0.53
HIF1A Q16665 1/20 0.53
TST Q16762 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554097 0.94 ESR1 (0.54) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL9552934 0.87 MEN1 (0.43) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL450038 0.85 ESR1 (0.59) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL9553062 0.83 TSHR (0.52) ALDH1A1HIF1AHSD17B10MEN1KMT2A
SCHEMBL9553703 0.83 TSHR (0.52) ALDH1A1HIF1AHSD17B10MEN1KMT2A
SCHEMBL7125488 0.82 OPRK1 (0.42) ESR1KDM4ECYP3A4HIF1AHSD17B10
SCHEMBL9671911 0.82 MEN1 (0.46) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL449737 0.82 ESR1 (0.77) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL1447579 0.79 ESR1 (0.77) ESR1ADRA2ASLC6A2ALDH1A1ADORA3
SCHEMBL7784766 0.79 ESR1 (0.77) ESR1ADRA2ASLC6A2ALDH1A1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112041165-B Additive manufacturing with efficient sintering using photothermal dyes 株式会社理光 2024-01-09 CN disclosed
CN-112041165-A Additive manufacturing using photothermal dyes for high efficiency sintering 株式会社理光 2020-12-04 CN disclosed
CN-107129659-B Method for solid freeform fabrication 株式会社理光 2020-11-24 CN disclosed
EP-1267874-A2 THERAPEUTIC USES OF PPAR MEDIATORS Aventis Pharma Deutschland GmbH (DE) 2003-01-02 EP disclosed
US-6376512-B1 FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-23 US disclosed
WO-2001066098-A2 THERAPEUTIC USES OF PPAR MEDIATORS AVENTIS PHARMA DEUTSCHLAND GMBH 2001-09-13 WO disclosed
US-5059610-A QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-10-22 US disclosed
US-4920132-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed